Molecular and cellular basis of hemoglobin switching

Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management, Second Edition

Volumn , Issue , 2009, Pages 86-100

  Stamatoyannopoulos, George ^a   Navas, Patrick A ^a   Li, Qiliang ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873993458     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511596582.009     Document Type: Chapter

References (182)

1. Huehns ER, Dance N, Beaven GH, Keil JV, Hecht F, Motulsky AG. Human embryonic haemoglobins. Nature. 1964;201:1095-1097.
2. Hecht F, Motulsky AG, Lemire RJ, Shepard TE. Predominance of hemoglobin Gower 1 in early human embryonic development. Science. 1966;152:91-92.
3. Gale RE, Clegg JB, Huehns ER. Human embryonic haemoglobins Gower 1 and Gower 2. Nature. 1979;280:162-164.
4. Papayannopoulou T, Shepard TH, Stamatoyannopoulos G. Studies of hemoglobin expression in erythroid cells of early human fetuses using antiγ-and anti-β-globin chain fluorescent antibodies. Prog Clin Biol Res. 1983;134:421-430.
5. Boyer SH, Belding TK, Margolet L, Noyes AN. Fetal hemoglobin restriction to a few erythrocytes (F cells) in normal human adults. Science. 1975;188:361-363.
6. Wood WG, Stamatoyannopoulos G, Lim G, Nute PE. F-cells in the adult: normal values and levels in individuals with hereditary and acquired elevations of Hb F. Blood. 1975;46:671-682.
7. Ingram VM. Embryonic red blood cell formation. Nature. 1972;235:338-339.
8. Weatherall DJ, Edwards JA, Donohoe WT. Haemoglobin and red cell enzyme changes in juvenile myeloid leukaemia. Br Med J. 1968;1:679-681.
9. Weatherall DJ, Clegg JB, Wood WG. A model for the persistence or reactivation of fetal haemoglobin production. Lancet. 1976;2:660-663.
10. Alter BP, Rappeport JM, Huisman TH, SchroederWA, Nathan DG. Fetal erythropoiesis following bone marrow transplantation. Blood. 1976;48:843-853.
11. Alter BP, Jackson BT, Lipton JM, et al. Control of the simian fetal hemoglobin switch at the progenitor cell level. J Clin Invest. 1981;67:458-466.
12. Alter BP, Jackson BT, Lipton JM, et al. Three classes of erythroid progenitors that regulate hemoglobin synthesis during ontogeny in the primate. In: Stamatoyannopoulos G, Nienhuis AW, eds. Hemoglobins in Development and Differentiation. New York: Alan R. Liss; 1981:331-340.
13. Papayannopoulou T, Brice M, Stamatoyannopoulos G. Hemoglobin F synthesis in vitro: evidence for control at the level of primitive erythroid stem cells. Proc Natl Acad Sci USA.1977;74:2923-2927.
14. Chapman BS, Tobin AJ. Distribution of developmentally regulated hemoglobins in embryonic erythroid populations. Dev Biol. 1979;69:375-387.
15. Brotherton TW, Chui DH, Gauldie J, Patterson M. Hemoglobin ontogeny during normal mouse fetal development. Proc Natl Acad Sci USA. 1979;76:2853-2857.
16. Le Douarin N. Ontogeny of hematopoietic organs studied in avian embryo interspecific chimeras. In: Clarkson B, Marks P, Till J, eds.Differentiation inNormal andNeoplasticHemopoietic Cells. New York: Cold Spring Harbor; 1978:5-31.
17. Beaupain D, Martin C, Dieterlen-Lievre F. Origin and evolution of hemopoietic stem cells in the avian embryo. In: Stamatoyannopoulos G, Nienhuis AW, eds. Hemoglobins in Development and Differentiation. New York: Alan R. Liss; 1981: 161-169.
18. Peschle C, Migliaccio AR, Migliaccio G, et al. Embryonic-Fetal Hb switch in humans: studies on erythroid bursts generated by embryonic progenitors from yolk sac and liver. Proc Natl Acad Sci USA. 1984;81:2416-2420.
19. Stamatoyannopoulos G, Constantoulakis P, Brice M, Kurachi S, Papayannopoulou T. Coexpression of embryonic, fetal, and adult globins in erythroid cells of human embryos: relevance to the cell-lineage models of globin switching. Dev Biol. 1987;123:191-197.
20. Stamatoyannopoulos G, Grosveld F. Hemoglobin switching. In: Stamatoyannopoulos G, Majerus P, Perlmutter R, Varmus H, eds. The Molecular Basis of Blood Diseases. 3rd ed. Philadelphia:W.B. Saunders Co.; 2001:135-182.
21. Papayannopoulou T, Brice M, Stamatoyannopoulos G. Analysis of human hemoglobin switching in MEL × human fetal erythroid cell hybrids. Cell. 1986;46:469-476.
22. Wintour EM, Smith MB, Bell RJ, McDougall JG, Cauchi MN. The role of fetal adrenal hormones in the switch from fetal to adult globin synthesis in the sheep. J Endocrinol. 1985;104:165-170.
23. Zitnik G, Li Q, Stamatoyannopoulos G, Papayannopoulou T. Serum factors can modulate the developmental clock of γ-to β-globin gene switching in somatic cell hybrids. Mol Cell Biol. 1993;13:4844-4851.
24. Zitnik G, Peterson K, Stamatoyannopoulos G, Papayannopoulou T. Effects of butyrate and glucocorticoids on γ-to β-globin gene switching in somatic cell hybrids. Mol Cell Biol. 1995;15:790-795.
25. Della Torre L, Meroni P. [Studies of fetal blood. I. Fetal and adult hemoglobin levels in normal pregnancy. Relation to fetal maturity]. Ann Ostet Ginecol Med Perinat. 1969;91:148-157.
26. Bard H, Makowski EL, Meschia G, Battaglia FC. The relative rates of synthesis of hemoglobins A and F in immature red cells of newborn infants. Pediatrics. 1970;45:766-772.
27. Zanjani ED, Lim G, McGlave PB, et al. Adult haematopoietic cells transplanted to sheep fetuses continue to produce adult globins. Nature. 1982;295:244-246.
28. Wood WG, Bunch C, Kelly S, Gunn Y, Breckon G. Control of haemoglobin switching by a developmental clock? Nature. 1985;313:320-323.
29. Holliday R, Pugh JE. DNA modification mechanisms and gene activity during development. Science. 1975;187:226-232.
30. Melis M, Demopulos G, Najfeld V, et al. A chromosome 11-linked determinant controls fetal globin expression and the fetal-to-adult globin switch. Proc Natl Acad Sci USA. 1987;84:8105-8109.
31. Stanworth SJ, Roberts NA, Sharpe JA, Sloane-Stanley JA, Wood WG. Established epigenetic modifications determine the expression of developmentally regulated globin genes in somatic cell hybrids. Mol Cell Biol. 1995;15:3969-3978.
32. Gong Q, Dean A. Enhancer-dependent transcription of the t-globin promoter requires promoter-bound GATA-1 and enhancer-bound AP-1/NF-E2. Mol Cell Biol. 1993;13: 911-917.
33. Gong QH, Stern J, Dean A. Transcriptional role of a conserved GATA-1 site in the human G-globin gene promoter. Mol Cell Biol. 1991;11:2558-2566.
34. Walters M, Martin DI. Functional erythroid promoters created by interaction of the transcription factor GATA-1 with CACCC and AP-1/NFE-2 elements. Proc Natl Acad Sci USA. 1992;89:10444-10448.
35. Filipe A, Li Q, Deveaux S, et al. Regulation of embryonic/fetal globin genes by nuclear hormone receptors: a novel perspective on hemoglobin switching. EMBO J. 1999;18:687-697.
36. Yu CY, Motamed K, Chen J, Bailey AD, Shen CK. The CACC box upstream of human embryonic bbglobin gene binds Sp1 and is a functional promoter element in vitro and in vivo. J Biol Chem. 1991;266:8907-8915.
37. Marin M, Karis A, Visser P, Grosveld F, Philipsen S. Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell. 1997;89:619-628.
38. Asano H, Li XS, Stamatoyannopoulos G. FKLF, a novel Kruppel-like factor that activates human embryonic and fetal β-like globin genes.Mol Cell Biol. 1999;19:3571-3579.
39. Asano H, Li XS, Stamatoyannopoulos G. FKLF-2: a novel Kruppel-like transcriptional factor that activates globin and other erythroid lineage genes. Blood. 2000;95:3578-3584.
40. Tanimoto K, Liu Q, Grosveld F, Bungert J, Engel JD. Contextdependent EKLF responsiveness defines the developmental specificity of the human s-globin gene in erythroid cells of YAC transgenic mice. Genes Dev. 2000;14:2778-2794.
41. Tanabe O, Katsuoka F, Campbell AD, et al. An embryonic/fetal β-type globin gene repressor contains a nuclear receptor TR2/TR4 heterodimer. EMBO J. 2002;21:3434-3442.
42. Tanabe O, McPhee D, Kobayashi S, et al. Embryonic and fetal β-globin gene repression by the orphan nuclear receptors, TR2 and TR4. EMBO J. 2007;26:2295-2306.
43. Raich N, Clegg CH, Grofti J, Romeo PH, Stamatoyannopoulos G. GATA1 and YY1 are developmental repressors of the human h-globin gene. EMBO J. 1995;14:801-809.
44. Li J, Noguchi CT, Miller W, Hardison R, Schechter AN. Multiple regulatory elements in the 5ʹ-flanking sequence of the human h-globin gene. J Biol Chem. 1998;273:10202-10209.
45. Trepicchio WL, Dyer MA, Baron MH. Developmental regulation of the human embryonic β-like globin gene is mediated by synergistic interactions among multiple tissue-and stagespecific elements. Mol Cell Biol. 1993;13:7457-7468.
46. Yi Z, Cohen-Barak O, Hagiwara N, et al. Sox6 directly silences 44globin expression in definitive erythropoiesis. PLoS Genet. 2006;2:e14.
47. Cohen-Barak O, Erickson DT, Badowski MS, et al. Stem cell transplantation demonstrates that Sox6 represses ty globin expression in definitive erythropoiesis of adult mice. Exp Hematol. 2007;35:358-367.
48. Gumucio DL, Heilstedt-Williamson H, Gray TA, et al. Phylogenetic footprinting reveals a nuclear protein which binds to silencer sequences in the human γ and ε aglobin genes. Mol Cell Biol. 1992;12:4919-4929
49. Jane SM, Ney PA, Vanin EF, Gumucio DL, Nienhuis AW. Identification of a stage selector element in the human γ-globin gene promoter that fosters preferential interaction with the 5ʹ HS2 enhancer when in competition with the β-promoter. EMBO J. 1992;11:2961-2969.
50. Jane SM, Gumucio DL, Ney PA, Cunningham JM, Nienhuis AW.Methylation-enhanced binding of Sp1 to the stage selector element of the human γ-globin gene promoter may regulate development specificity of expression. Mol Cell Biol. 1993;13:3272-3281.
51. Jane SM, Nienhuis AW, Cunningham JM. Hemoglobin switching in man and chicken is mediated by a heteromeric complex between the ubiquitous transcription factor CP2 and a developmentally specific protein. EMBO J. 1995;14:97-105.
52. Zhou WL, Clouston X, Wang L, Cerruti J, Cunningham JM, Jane SM. Isolation and characteriztion of human NF-E4, the tissue restricted component of the stage selector protein complex. Blood. 1999;94(Suppl 1):614a.
53. Gumucio DL, Rood KL, Gray TA, Riordan MF, Sartor CI, Collins FS. Nuclear proteins that bind the human γ-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin. Mol Cell Biol. 1988;8:5310-5322.
54. Mantovani R, Malgaretti N, Nicolis S, Ronchi A, Giglioni B, Ottolenghi S. The effects of HPFH mutations in the human γ-globin promoter on binding of ubiquitous and erythroid specific nuclear factors. Nucl Acids Res. 1988;16:7783-7797.
55. Mantovani R, Superti-Furga G, Gilman J, Ottolenghi S. The deletion of the distal CCAAT box region of the A γ-globin gene in black HPFH abolishes the binding of the erythroid specific protein NFE3 and of the CCAAT displacement protein. Nucl Acids Res. 1989;17:6681-6691.
56. Fucharoen S, Shimizu K, Fukumaki Y. A novel C-T transition within the distal CCAAT motif of the G γ-globin gene in the Japanese HPFH: implication of factor binding in elevated fetal globin expression. Nucl Acids Res. 1990;18:5245-5253.
57. McDonagh K, Nienhuis AW. Induction of the human γ-globin gene promoter in K562 cells by sodium butyrate: Reversal of repression by CCAAT displacement protein. Blood. 1991;78:255a.
58. Berry M, Grosveld F, Dillon N. A single point mutation is the cause of the Greek form of hereditary persistence of fetal haemoglobin. Nature. 1992;358:499-502.
59. Skalnik DG, Strauss EC, Orkin SH. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J Biol Chem. 1991;266:16736-16744.
60. Ronchi AE, Bottardi S, Mazzucchelli C, Ottolenghi S, Santoro C. Differential binding of the NFE3 and CP1/NFY transcription factors to the human γ-and ε globin CCAAT boxes. J Biol Chem. 1995;270:21934-21941.
61. Ronchi A, Berry M, Raguz S, et al. Role of the duplicated CCAAT box region in γ-globin gene regulation and hereditary persistence of fetal haemoglobin. EMBO J. 1996;15:143-149.
62. Li Q, Fang X, Olave I, et al. Transcriptional potential of the γ-globin gene is dependent on the CACCC box in a developmental stage-specific manner. Nucl Acids Res. 2006;34:3909-3916.
63. McDonagh KT, Lin HJ, Lowrey CH, Bodine DM, Nienhuis AW. The upstream region of the human γ-globin gene promoter. Identification and functional analysis of nuclear protein binding sites. J Biol Chem. 1991;266:11965-11974.
64. Magis W, Martin DI. HMG-I binds to GATA motifs: implications for an HPFH syndrome. Biochem Biophys Res Commun. 1995;214:927-933.
65. Ulrich MJ, Gray WJ, Ley TJ. An intramolecular DNA triplex is disrupted by point mutations associated with hereditary persistence of fetal hemoglobin. J Biol Chem. 1992;267:18649-18658.
66. Bacolla A, Ulrich MJ, Larson JE, Ley TJ, Wells RD. An intramolecular triplex in the human γ-globin 5ʹ-flanking region is altered by point mutations associated with hereditary persistence of fetal hemoglobin. J Biol Chem. 1995;270: 24556-24563.
67. Ponce E, Lloyd JA, Pierani A, Roeder RG, Lingrel JB. Transcription factor OTF-1 interacts with two distinct DNA elements in the A γ-globin gene promoter. Biochemistry. 1991;30:2961-2967.
68. Stamatoyannopoulos G, Josephson B, Zhang JW, Li Q. Developmental regulation of human γ-globin genes in transgenic mice.Mol Cell Biol. 1993;13:7636-7644.
69. Pace BS, Li Q, Stamatoyannopoulos G. In vivo search for butyrate responsive sequences using transgenic mice carrying A γ gene promoter mutants. Blood. 1996;88:1079-1083.
70. Luo HY, Mang D, Patrinos GP, et al. A mutation in a GATA-1 binding site 5' to the Gγ-globin gene (nt-567, T>G) may be associated with increased levels of fetal hemoglobin. Blood. 2004;104:500.
71. Peterson KR, Costa FC, Harju-Baker S. Silencing of γ-globin gene expression during adult definitive erythropoiesis is mediated by a GATA-1 repressor complex. Blood. 2007;110:271.
72. Ahringer J. NuRD and SIN3 histone deacetylase complexes in development. Trends Genet. 2000;16:351-356.
73. Bowen NJ, Fujita N, Kajita M, Wade PA. Mi-2/NuRD: multiple complexes for many purposes. Biochim Biophys Acta. 2004;1677:52-57.
74. Le Guezennec X, Vermeulen M, Brinkman AB, et al. MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol Cell Biol. 2006;26:843-851.
75. Bodine DM, Ley TJ. An enhancer element lies 3ʹ to the human A γ globin gene. EMBO J. 1987;6:2997-3004.
76. Purucker M, Bodine D, Lin H, McDonagh K, Nienhuis AW. Structure and function of the enhancer 3ʹ to the human A γ globin gene. Nucl Acids Res. 1990;18:7407-7415.
77. Dickinson LA, Joh T, Kohwi Y, Kohwi-Shigematsu T. A tissuespecific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell. 1992;70:631-645.
78. Liu Q, Tanimoto K, Bungert J, Engel JD. The A γ-globin 3ʹ element provides no unique function(s) for human β-globin locus gene regulation. Proc Natl Acad Sci USA. 1998;95:9944-9949.
79. Li Q, Stamatoyannopoulos JA. Position independence and proper developmental control of γ-globin gene expression require both a 5ʹ locus control region and a downstream sequence element. Mol Cell Biol. 1994;14:6087-6096.
80. Stamatoyannopoulos JA, Clegg CH, Li Q. Sheltering of γ-globin expression from position effects requires both an upstream locus control region and a regulatory element 3' to the A g-globin gene. Mol Cell Biol. 1997;17:240-247.
81. Duan ZJ, Fang X, Rohde A, Han H, Stamatoyannopoulos G, Li Q. Developmental specificity of recruitment of TBP to the TATA box of the human γ-globin gene. Proc Natl Acad Sci USA. 2002;99:5509-5514.
82. Fang X, Han H, Stamatoyannopoulos G, Li Q. Developmentally specific role of the CCAAT box in regulation of human γ-globin gene expression. J Biol Chem. 2004;279:5444-5449.
83. Li Q, Han H, Ye X, Stafford M, Barkess G, Stamatoyannopoulos G. Transcriptional potentials of the β-like globin genes at different developmental stages in transgenic mice and hemoglobin switching. Blood Cells Mol Dis. 2004;33: 318-325.
84. Antoniou M, deBoer E, Habets G, Grosveld F. The human β-globin gene contains multiple regulatory regions: identification of one promoter and two downstream enhancers. EMBO J. 1988;7:377-384.
85. deBoer E, Antoniou M, Mignotte V, Wall L, Grosveld F. The human β-globin promoter; nuclear protein factors and erythroid specific induction of transcription. EMBO J. 1988;7:4203-4212.
86. Wall L, Destroismaisons N, Delvoye N, Guy LG. CAAT/enhancer-binding proteins are involved in β-globin gene expression and are differentially expressed in murine erythroleukemia and K562 cells. J Biol Chem. 1996;271: 16477-16484.
87. Hartzog GA, Myers RM.Discrimination among potential activators of the β-globin CACCC element by correlation of binding and transcriptional properties. Mol Cell Biol. 1993;13:44-56.
88. Miller IJ, Bieker JJ. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Mol Cell Biol. 1993;13:2776-2786.
89. Feng WC, Southwood CM, Bieker JJ. Analyses of β-thalassemia mutant DNA interactions with erythroid Kruppel-like factor (EKLF), an erythroid cell-specific transcription factor. J Biol Chem. 1994;269:1493-1500.
90. Donze D, Townes TM, Bieker JJ. Role of erythroid Kruppellike factor in human γ-to β-globin gene switching. J Biol Chem. 1995;270:1955-1959.
91. Behringer RR, Hammer RE, Brinster RL, Palmiter RD, Townes TM. Two 3ʹ sequences direct adult erythroid-specific expression of human β-globin genes in transgenic mice. Proc Natl Acad Sci USA. 1987;84:7056-7060.
92. Kollias G, Hurst J, deBoer E, Grosveld F. The human β-globin gene contains a downstream developmental specific enhancer. Nucl Acids Res. 1987;15:5739-5747.
93. Trudel M, Costantini F. A 3ʹ enhancer contributes to the stage-specific expression of the human β-globin gene. Genes Dev. 1987;1:954-961.
94. Liu Q, Bungert J, Engel JD.Mutation of gene-proximal regulatory elements disrupts human ε-, γ-, and β-globin expression in yeast artificial chromosome transgenic mice. Proc Natl Acad Sci USA. 1997;94:169-174.
95. Rubin JE, Pasceri P, Wu X, Leboulch P, Ellis J. Locus control region activity by 5'HS3 requires a functional interaction with β-globin gene regulatory elements: expression of novel β/γ-globin hybrid transgenes. Blood. 2000;95:3242-3249.
96. Bharadwaj RR, Trainor CD, Pasceri P, Ellis J. LCR-regulated transgene expression levels depend on the Oct-1 site in the AT-rich region of β-globin intron-2. Blood. 2003;101:1603-1610.
97. Tuan D, Solomon W, Li Q, London IM. The "β-like-globin" gene domain in human erythroid cells. Proc Natl Acad Sci USA. 1985;82:6384-6388.
98. ForresterWC, Thompson C, Elder JT, Groudine M. A developmentally stable chromatin structure in the human β-globin gene cluster. Proc Natl Acad Sci USA. 1986;83:1359-1363.
99. Grosveld F, van Assendelft GB, Greaves DR, Kollias G. Position-independent, high-level expression of the human β-globin gene in transgenic mice. Cell. 1987;51:975-985.
100. Fraser P, Grosveld F. Locus control regions, chromatin activation and transcription. Curr Opin Cell Biol. 1998;10:361-365.
101. Milot E, Strouboulis J, Trimborn T, et al. Heterochromatin effects on the frequency and duration of LCR-mediated gene transcription. Cell. 1996;87:105-114.
102. Epner E, Reik A, Cimbora D, et al. The β-globin LCR is not necessary for an open chromatin structure or developmentally regulated transcription of the native mouse β-globin locus. Mol Cell. 1998;2:447-455.
103. Reik A, Telling A, Zitnik G, Cimbora D, Epner E, Groudine M. The locus control region is necessary for gene expression in the human β-globin locus but not the maintenance of an open chromatin structure in erythroid cells. Mol Cell Biol. 1998;18:5992-6000.
104. Bender MA, Bulger M, Close J, Groudine M. β-globin gene switching andDNase I sensitivity of the endogenous β-globin locus in mice do not require the locus control region. Mol Cell. 2000;5:387-393.
105. Van Der Ploeg LH, Konings A, Oort M, Roos D, Bernini L, Flavell RA. γ-β-Thalassaemia studies showing that deletion of the γ-and δ-genes influences β-globin gene expression in man. Nature. 1980;283:637-642.
106. Vanin EF, Henthorn PS, Kioussis D, Grosveld F, Smithies O. Unexpected relationships between four large deletions in the human β-globin gene cluster. Cell. 1983;35:701-709.
107. Curtin P, Pirastu M, Kan YW, Gobert-Jones JA, Stephens AD, Lehmann H. A distant gene deletion affects β-globin gene function in an atypical γ δβ-thalassemia. J Clin Invest. 1985;76:1554-1558.
108. Driscoll MC, Dobkin CS, Alter BP. γ δβ-thalassemia due to a de novo mutation deleting the 5ʹ β-globin gene activationregion hypersensitive sites. Proc Natl Acad Sci USA. 1989; 86:7470-7474.
109. Forrester WC, Epner E, Driscoll MC, et al. A deletion of the human β-globin locus activation region causes a major alteration in chromatin structure and replication across the entire β-globin locus. Genes Dev. 1990;4:1637-1649.
110. Bender MA, Byron R, Ragoczy T, Telling A, Bulger M, Groudine M. Flanking HS-62.5 and 3ʹ HS1, and regions upstream of the LCR, are not required for β-globin transcription. Blood. 2006;108:1395-1401.
111. Higgs DR. Do LCRs open chromatin domains? Cell. 1998; 95:299-302.
112. Grosveld F. Activation by locus control regions? Curr Opin Genet Dev. 1999;9:152-157.
113. Fraser P, Pruzina S, Antoniou M, Grosveld F. Each hypersensitive site of the human β-globin locus control region confers a different developmental pattern of expression on the globin genes. Genes Dev. 1993;7:106-113.
114. Navas PA, Peterson KR, Li Q, et al. Developmental specificity of the interaction between the locus control region and embryonic or fetal globin genes in transgenic mice with an HS3 core deletion. Mol Cell Biol. 1998;18:4188-4196.
115. Raich N, Enver T, Nakamoto B, Josephson B, Papayannopoulou T, Stamatoyannopoulos G. Autonomous developmental control of human embryonic globin gene switching in transgenic mice. Science. 1990;250:1147-1149.
116. Shih DM, Wall RJ, Shapiro SG. Developmentally regulated and erythroid-specific expression of the human embryonic β-globin gene in transgenic mice. Nucl Acids Res. 1990;18:5465-5472.
117. Wada-Kiyama Y, Peters B, Noguchi CT. The 1-globin gene silencer. Characterization by in vitro transcription. J Biol Chem. 1992;267:11532-11538.
118. Li Q, Blau CA, Clegg CH, Rohde A, Stamatoyannopoulos G Multiple M-promoter elements participate in the developmental control of c-globin genes in transgenic mice. J Biol Chem. 1998;273:17361-17367.
119. Cao SX, Gutman PD, Dave HP, Schechter AN. Negative control of the human c-globin gene. Prog Clin Biol Res. 1989;316A:279-289.
120. Peters B, Merezhinskaya N, Diffley JF, Noguchi CT. Protein-DNA interactions in the D-globin gene silencer. J Biol Chem. 1993;268:3430-3437.
121. Raich N, Papayannopoulou T, Stamatoyannopoulos G, Enver T. Demonstration of a human T-globin gene silencer with studies in transgenic mice. Blood. 1992;79:861-864.
122. Li Q, Clegg C, Peterson K, Shaw S, Raich N, Stamatoyannopoulos G. Binary transgenic mouse model for studying the trans control of globin gene switching: evidence that GATA-1 is an in vivo repressor of human GGgene expression. Proc Natl Acad Sci USA. 1997;94:2444-2448.
123. Navas PA, Li Q, Peterson KR, Stamatoyannopoulos G. Investigations of a human embryonic globin gene silencing element using YAC transgenic mice. Exp Biol Med (Maywood). 2006;231:328-334.
124. Behringer RR, Ryan TM, Palmiter RD, Brinster RL, Townes TM. Human γ-to β-globin gene switching in transgenic mice. Genes Dev. 1990;4:380-389.
125. Enver T, Raich N, Ebens AJ, Papayannopoulou T, Costantini F, Stamatoyannopoulos G. Developmental regulation of human fetal-to-adult globin gene switching in transgenic mice. Nature. 1990;344:309-313.
126. Dillon N, Grosveld F. Human γ-globin genes silenced independently of other genes in the β-globin locus. Nature. 1991;350:252-254.
127. Peterson KR, Li QL, Clegg CH, et al. Use of yeast artificial chromosomes (YACs) in studies of mammalian development: production of β-globin locus YAC mice carrying human globin developmental mutants. Proc Natl Acad Sci USA. 1995;92:5655-5659.
128. Dillon N, Trimborn T, Strouboulis J, Fraser P, Grosveld F. The effect of distance on long-range chromatin interactions. Mol Cell. 1997;1:131-139.
129. Harju S, Navas PA, Stamatoyannopoulos G, Peterson KR. Genome architecture of the human β-globin locus affects developmental regulation of gene expression. Mol Cell Biol. 2005;25:8765-8778.
130. Yu M, Han H, Xiang P, Li Q, Stamatoyannopoulos G. Autonomous silencing as well as competition controls γ-globin gene expression during development. Mol Cell Biol. 2006;26:4775-4781.
131. Hanscombe O, Whyatt D, Fraser P, et al. Importance of globin gene order for correct developmental expression. Genes Dev. 1991;5:1387-1394.
132. Peterson KR, Stamatoyannopoulos G. Role of gene order in developmental control of human γ-and β-globin gene expression. Mol Cell Biol. 1993;13:4836-4843.
133. Wijgerde M, Grosveld F, Fraser P. Transcription complex stability and chromatin dynamics in vivo. Nature. 1995;377:209-213.
134. Dekker J, Rippe K, Dekker M, Kleckner N. Capturing chromosome conformation. Science. 2002;295:1306-1311.
135. Tolhuis B, Palstra RJ, Splinter E, Grosveld F, de Laat W. Looping and interaction between hypersensitive sites in the active β-globin locus. Mol Cell. 2002;10:1453-1465.
136. Palstra RJ, Tolhuis B, Splinter E, Nijmeijer R, Grosveld F, de Laat W. The β-globin nuclear compartment in development and erythroid differentiation. Nat Genet. 2003;35:190-194.
137. Carter D, Chakalova L, Osborne CS, Dai YF, Fraser P. Longrange chromatin regulatory interactions in vivo. Nat Genet. 2002;32:623-626.
138. Drissen R, Palstra RJ, Gillemans N, et al. The active spatial organization of the β-globin locus requires the transcription factor EKLF. Genes Dev. 2004;18:2485-2490.
139. Vakoc CR, Letting DL, Gheldof N, et al. Proximity among distant regulatory elements at the β-globin locus requires GATA-1 and FOG-1. Mol Cell. 2005;17:453-462.
140. Kooren J, Palstra RJ, Klous P, et al. B-globin active chromatin Hub formation in differentiating erythroid cells and in p45 NF-E2 knock-out mice. J Biol Chem. 2007;282:16544-16552.
141. Papayannopoulou TH, Brice M, Stamatoyannopoulos G. Stimulation of fetal hemoglobin synthesis in bone marrow cultures from adult individuals. Proc Natl Acad Sci USA. 1976;73:2033-2037.
142. Stamatoyannopoulos G, Veith R, Galanello R, Papayannopoulou T. Hb F production in stressed erythropoiesis: observations and kinetic models. Ann NY Acad Sci. 1985; 445:188-197.
143. Papayannopoulou T, Vichinsky E, Stamatoyannopoulos G. Fetal Hb production during acute erythroid expansion. I. Observations in patients with transient erythroblastopenia and post-phlebotomy. Br J Haematol. 1980;44:535-546.
144. Sheridan BL, Weatherall DJ, Clegg JB, et al. The patterns of fetal haemoglobin production in leukaemia. Br J Haematol. 1976;32:487-506.
145. DeSimone J, Biel SI, Heller P. Stimulation of fetal hemoglobin synthesis in baboons by hemolysis and hypoxia. Proc Natl Acad Sci USA. 1978;75:2937-2940.
146. Nute PE, Papayannopoulou T, Chen P, Stamatoyannopoulos G. Acceleration of F-cell production in response to experimentally induced anemia in adult baboons (Papio cynocephalus). Am J Hematol. 1980;8:157-168.
147. Al-Khatti A, Veith RW, Papayannopoulou T, Fritsch EF, Goldwasser E, Stamatoyannopoulos G. Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons. N Engl J Med. 1987;317:415-420.
148. Umemura T, Al-Khatti A, Papayannopoulou T, Stamatoyannopoulos G. Fetal hemoglobin synthesis in vivo: direct evidence for control at the level of erythroid progenitors. Proc Natl Acad Sci USA. 1988;85:9278-9282.
149. Beaven GH, Ellis MJ, White JC. Studies on human foetal haemoglobin. II. Foetal haemoglobin levels in healthy children and adults and in certain haematological disorders. Br J Haematol. 1960;6:201-222.
150. Stamatoyannopoulos G, Papayannopoulou T. Fetal hemoglobin and the erythroid stem cell differentiation process. In: Stamatoyannopoulos G, Nienhuis AW, eds. Cellular and Molecular Regulation of Hemoglobin Switching. New York: Grune & Stratton; 1979:323-349.
151. DeSimone J, Heller P, Hall L, Zwiers D. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc Natl Acad Sci USA. 1982;79:4428-4431.
152. Ley TJ, DeSimone J, Anagnou NP, et al. 5-azacytidine selectively increases γ-globin synthesis in a patient with b+thalassemia.NEngl J Med. 1982;307:1469-1475.
153. Torrealba de Ron AT, Papayannopoulou T, Knapp MS, Fu MF, Knitter G, Stamatoyannopoulos G. Perturbations in the erythroid marrow progenitor cell pools may play a role in the augmentation of HbF by 5-azacytidine. Blood. 1984;63:201-210.
154. Papayannopoulou T, Torrealba de Ron A, Veith R, Knitter G, Stamatoyannopoulos G. Arabinosylcytosine induces fetal hemoglobin in baboons by perturbing erythroid cell differentiation kinetics. Science. 1984;224:617-619.
155. Letvin NL, Linch DC, Beardsley GP, McIntyre KW, Nathan DG. Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. N Engl J Med. 1984;310:869-873.
156. Veith R, Papayannopoulou T, Kurachi S, Stamatoyannopoulos G. Treatment of baboon with vinblastine: insights into the mechanisms of pharmacologic stimulation of Hb F in the adult. Blood. 1985;66:456-459.
157. Fibach E, Burke LP, Schechter AN, Noguchi CT, Rodgers GP. Hydroxyurea increases fetal hemoglobin in cultured erythroid cells derived from normal individuals and patients with sickle cell anemia or β-thalassemia. Blood. 1993;81: 1630-1635.
158. Platt OS, Falcone JF.Membrane protein interactions in sickle red blood cells: evidence of abnormal protein 3 function. Blood. 1995;86:1992-1998.
159. Steinberg MH, Lu ZH, Barton FB, Terrin ML, Charache S, Dover GJ. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter study of hydroxyurea. Blood. 1997;89:1078-1088.
160. Perrine SP, Greene MF, Faller DV. Delay in the fetal globin switch in infants of diabetic mothers. N Engl J Med. 1985; 312:334-338.
161. Perrine SP, Miller BA, Greene MF, et al. Butryic acid analogues augment γ globin gene expression in neonatal erythroid progenitors. Biochem Biophys Res Commun. 1987;148: 694-700.
162. Constantoulakis P, Papayannopoulou T, Stamatoyannopoulos G. α-Amino-N-butyric acid stimulates fetal hemoglobin in the adult. Blood. 1988;72:1961-1967.
163. Perrine SP, Miller BA, Faller DV, et al. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and b thalassemia. Blood. 1989;74:454-459.
164. Stamatoyannopoulos G, Nienhuis AW. Hemoglobin switching. In: Stamatoyannopoulos G, Nienhuis AW, Majerus P, Varmus H, eds. Molecular Basis of Blood Diseases. 2nd ed. Philadelphia:W.B. Saunders Co.; 1994:107-154.
165. Liakopoulou E, Blau CA, Li Q, et al. Stimulation of fetal hemoglobin production by short chain fatty acids. Blood. 1995;86:3227-3235.
166. Dover GJ, Brusilow S, Charache S. Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood. 1994;84:339-343.
167. Collins AF, Dover GJ, Luban NL. Increased fetal hemoglobin production in patients receiving valproic acid for epilepsy. Blood. 1994;84:1690-1691.
168. Little JA, Dempsey NJ, Tuchman M, Ginder GD. Metabolic persistence of fetal hemoglobin. Blood. 1995;85:1712-1718.
169. Peters A, Rohloff D, Kohlmann T, et al. Fetal hemoglobin in starvation ketosis of young women. Blood. 1998;91:691-694.
170. Cao H, Stamatoyannopoulos G, Jung M. Induction of human γ globin gene expression by histone deacetylase inhibitors. Blood. 2004;103:701-709.
171. Pace BS, White GL, Dover GJ, Boosalis MS, Faller DV, Perrine SP. Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo. Blood. 2002;100:4640-4648.
172. Kuo MH, Brownell JE, Sobel RE, et al. Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines. Nature. 1996;383:269-272.
173. Mizzen CA, Yang XJ, Kokubo T, et al. The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell. 1996;87:1261-1270.
174. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 1996;87:953-959.
175. Vettese-Dadey M, Grant PA, Hebbes TR, Crane-Robinson C, Allis CD, Workman JL. Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. EMBO J. 1996;15:2508-2518.
176. Pace B, Li Q, Peterson K, Stamatoyannopoulos G. α-Amino butyric acid cannot reactivate the silenced γ gene of the β locus YAC transgenic mouse. Blood. 1994;84:4344-4353.
177. Uda M, Galanello R, Sanna S, et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of β-thalassemia. Proc Natl Acad Sci USA. 2008;105:1620-1625.
178. Lettre G, Sankaran VG, Bezerra MA, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and β-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci USA. 2008;105:11869-11874.
179. Sankaran VG, Menne TF, Xu J, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science. 2008;322:1839-1842.
180. Senawong T, Peterson VJ, Leid M. BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression. Arch Biochem Biophys. 2005;434:316-325.
181. Liu H, Ippolito GC, Wall JK, et al. Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells. Mol cancer. 2006;5:18-34.
182. Chen, Z, Luo, HY, Steinberg, MH, Chui DH. BCL11A represses HBG transcription in K562 cells. Blood Cells Mol Dis. 2009;42:144-149.